Trial Profile
Multicenter randomized controlled study comparing the efficacy and safety of natural Multi-subtype interferon alpha (Multiferon) in association with ribavirin versus retreatment with pegylated interferon-alpha 2a and ribavirin in non-responding genotype 1 hepatitis C patients.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Swedish Orphan
- 17 Jun 2011 New trial record